Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...

How could patients with advanced breast cancer survive more than twenty years after a simple vaccine trial? This medical observation piqued the curiosity of scientists, who decided to reexamine ...

Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based ...

For almost 60 years, scientists have tried to understand why DNA doesn't replicate wildly and uncontrollably every time a ...

The segment spotlighted the Baylor-led research recently published in Nature Medicine evaluating autologous Multi-Antigen Targeted T cell therapy in patients with pancreatic ductal adenocarcinoma ...

Researchers at MIT and Stanford University have developed a new way to stimulate the immune system to attack tumor cells, using a strategy that could make cancer immunotherapy work for many ...

Cardiologists have spent decades trying to stabilize the fatty plaques that clog arteries, but a new wave of immunotherapy is going after the diseased cells at the heart of the problem. In mice, an ...

Tumours have developed many strategies and tricks to gain advantages in the body. Led by cell biology professor Sabine Werner, researchers at ETH Zurich have now discovered another surprising trick ...

A team led by researchers at Baylor College of Medicine has identified flavonoids, natural compounds found in plants, that are toxic to bladder cancer cells cultured in the lab. The researchers report ...

Blood cancer patients will no longer be able to receive a life-extending treatment after the NHS watchdog scrapped its use.

Emerging immunotherapies and targeted therapies take aim at recently identified biomarkers ...

Experts discuss the small but promising study.